Observed isavuconazole exposure: 5-year experience of azole TDM from a Spanish reference laboratory.
Med Mycol
; 61(8)2023 Aug 02.
Article
en En
| MEDLINE
| ID: mdl-37580172
Optimizing azole therapy is a challenge in clinical practice, for which therapeutic drug monitoring is of great value to assess exposure, especially by using valid methodologies. Isavuconazole reaches good blood concentrations, but moderate intra-patient variability and different exposure according to the patient's age were found.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Azoles
/
Antifúngicos
Tipo de estudio:
Guideline
Límite:
Animals
Idioma:
En
Revista:
Med Mycol
Asunto de la revista:
MEDICINA VETERINARIA
/
MICROBIOLOGIA
Año:
2023
Tipo del documento:
Article
País de afiliación:
España
Pais de publicación:
Reino Unido